Yes, insulin doses often need to be adjusted when using GLP-1 for type 1 diabetes because glucose levels and food intake may change
In addition, treatment in this group of patients is complicated by multimorbidity, the need of polypharmacotherapy, and patient non-compliance
The vasomodulatory effects of GLP-1RAs also extend to glaucoma models, although the observed outcomes differ
PMID: 31209817 Res Sq2026 Mar 5
The experiment met the requirements of animal ethics with IRB no
Why Semaglutide Is Used in Peptide Protocols Semaglutide is commonly included in protocols intended to support: Appetite regulation and satiety signaling Reduced food cravings and portion control support Metabolic balance and glucose regulation Weight management consistency over time Improved adherence to nutrition-focused plans Individual experiences vary, and outcomes depend on adherence, lifestyle factors, and clinical oversight